Regenicin, Inc. (RGIN)
OTCMKTS · Delayed Price · Currency is USD
0.0000
-0.0003 (-99.67%)
At close: Dec 31, 2025
Regenicin Market Cap
Regenicin has a market cap or net worth of $153 as of January 23, 2026. Its market cap has decreased by -100.00% in one year.
Market Cap
153.00
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since November 16, 2009, Regenicin's market cap has decreased from 2.17M to 153.00, a decrease of -99.99%. That is a compound annual growth rate of -44.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 153.00 | -99.80% |
| Dec 29, 2022 | 76.74K | -95.00% |
| Dec 31, 2021 | 1.53M | -33.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nanobac Pharmaceuticals | 250.00 |
| NanoLogix | 163.00 |
| Poniard Pharmaceuticals | 150.00 |
| Q BioMed | 145.00 |
| NexImmune | 139.00 |
| PsyBio Therapeutics | 133.00 |
| Marizyme | 132.00 |
| RVL Pharmaceuticals | 111.00 |